CDNA (US)


February 4, 2026

CareDx (CDNA): Coverage Risks Coming?

By John Leppard

We view CareDx (CDNA) as having potentially asymmetric downside risk going into the final MolDx local coverage determination (LCD) on organ transplant rejection, which we would expect to be released in the next 1-2 months…

Read More >>